Cohort of Patients With Systemic Sclerosis Within the Framework of the RESO Reference Centre

Recruiting now · Not applicable

Conditions studied: Scleroderma, Systemic Sclerosis

In brief

Systemic sclerosis (SSc) is a rare form of connective tissue disease characterized by vascular involvement and the intensity of fibrosis. The lack of available treatment is largely due to the very fragmented understanding of the pathophysiology of SSc. However, one of the keys to conducting quality research on this disease remains the development of well-documented patient cohorts with reliable biological samples. The main objective of this cohort is to study the natural progression of SSc in a cohort of patients followed over 5 years.

Key facts

Study ID

NCT04265144

Run by

University Hospital, Bordeaux

People needed

500

Starts

2020-06-08

Expected to finish

2034-06-01

Last updated by the study team

2025-09-04

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patient over 18 years old
• Patient with systemic scleroderma according to the ACR/EULAR 2013 criteria, or with a " very early systemic sclerosis " defined by the presence of Raynaud's phenomenon and auto-antibodies in blood sample (ACAN positivity (≥1/160) with anti-Scl70, anti-centromere or anti-ARNPolIII specificity).
• Person affiliated or benefiting from a social security scheme.
• Free, informed and written consent signed by the participant and the investigator (no later than the day of inclusion and prior to any review required by the research)

You may not qualify if…

• Pregnant or breastfeeding woman
• Patient under guardianship, curatorship or any other legal protection regime

Where it is running

• CHU de Bordeaux - service de rhumatologie — Bordeaux, France (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.